R&D Structure Spanning Three Domestic and Overseas Sites
First written in FY2016. 23 of 30 entries say "Restated". Latest entry: FY2027-H1.
1 other company's latest entry also says "Other".
- FY2027-H1Lower R&D expenses in the interim periodAnnual report
「The group’s research and development activities totaled ¥107 million during the interim consolidated accounting period.」
Interim-period research and development expenses were ¥107 million, down from ¥113 million in the same period of the previous year. The company states that there were no material changes in its research and development activities. - FY2026Decrease in full-year R&D expensesAnnual report
「The current R&D structure consists of 3 sites: the Technical Center on the Kasai Plant premises, the Research Center on the Nagasaki Plant premises, and the Thailand Technical Center at the Thai subsidiary. R&D expenses for the consolidated fiscal year were ¥219 million.」
The company continued its 3-site R&D structure, with full-year R&D expenses of ¥219 million, down from ¥243 million in the previous fiscal year. - FY2026-H1Lower R&D expenses in the interim periodAnnual report
「The Group's total R&D expenses for the interim consolidated accounting period were ¥113 million.」
Interim R&D expenses were ¥113 million, down from ¥124 million in the same period of the previous year. The company states that there were no material changes in the status of its R&D activities. - FY2025-H1Higher interim-period R&D expensesAnnual report
「The group’s R&D activity costs for the interim consolidated accounting period were ¥124 million. There were no material changes in the status of the group’s R&D activities during the interim consolidated accounting period.」
The company states that there were no material changes in the status of its R&D activities, while disclosing R&D expenses of ¥124 million. This was an increase from ¥112 million in the same period of the previous year. - FY2024-Q3RestatedAnnual report
「The group’s R&D activity costs for the cumulative third-quarter consolidated period were ¥165 million. There were no material changes in the status of the group’s R&D activities during the cumulative third-quarter consolidated period.」
The company states that there have been no material changes in its domestic and overseas R&D structure, and discloses cumulative third-quarter R&D activity costs of ¥165 million. - FY2024-Q2RestatedAnnual report
「The Group's research and development expenditure during the current second-quarter consolidated cumulative period was ¥112 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The company states that there have been no material changes in its R&D structure, and discloses cumulative second-quarter R&D activity costs of ¥112 million. - FY2024-Q1RestatedAnnual report
「The total amount of R&D activities undertaken by the Group during the three-month period ended Q1 was ¥59 million. There were no material changes in the status of the Group's R&D activities during the three-month period ended Q1.」
The company states that there have been no material changes in its domestic and overseas R&D sites or coordination structure, and discloses cumulative first-quarter R&D activity costs of ¥59 million. - FY2023-Q3RestatedAnnual report
「The group's total research and development expenditure for the first 9 months of the current consolidated cumulative period was ¥145 million. There were no material changes in the status of the group's research and development activities during the first 9 months of the current consolidated cumulative period.」
The company states that there have been no material changes in its domestic and overseas R&D sites or coordination structure, and discloses cumulative third-quarter R&D activity costs of ¥145 million. - FY2022SoftenedAnnual report
「The current R&D structure consists of 3 sites: the Technical Center on the Kasai Plant premises, the Research Center on the Nagasaki Plant premises, and the Thailand Technical Center at the Thai subsidiary.」
This filing describes a 3-site structure spanning Kasai, Nagasaki and Thailand, compared with the 4-site structure including the Advanced Development Office shown in the previous fiscal year. - FY2022-Q3RestatedAnnual report
「Research and development expenditure for the Group as a whole during the nine-month cumulative consolidated period under review was ¥166 million. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period under review.」
The company states that there have been no material changes in its domestic and overseas R&D sites or coordination structure, and discloses R&D activity costs of ¥166 million. - FY2022-Q2RestatedAnnual report
「Research and development expenditure for the Group as a whole during the six-month cumulative consolidated period under review was ¥123 million. There were no material changes in the status of the Group's research and development activities during the six-month cumulative consolidated period under review.」
The company states that there have been no material changes in its domestic and overseas R&D sites or coordination structure, and discloses R&D activity costs of ¥123 million. - FY2022-Q1RestatedAnnual report
「Group-wide research and development expenditure for the three months ended the first quarter was ¥55 million. There were no material changes in the status of the group's research and development activities during the three months ended the first quarter.」
The company states that there have been no material changes in its domestic and overseas R&D sites or coordination structure, and discloses R&D activity costs of ¥55 million. - FY2021AdvancedAnnual report
「The current R&D structure consists of 4 sites: the Advanced Development Office and Research Center on the Nagasaki Plant premises, the Technical Center on the Kasai Plant premises, and the Thailand Technical Center at the Thai subsidiary.」
The company’s former 3-site structure spanning Kasai, Nagasaki and Thailand developed into a 4-site structure with the addition of the Advanced Development Office established in March 2021. - FY2021-Q3RestatedAnnual report
「Research and development expenditure for the Group as a whole during the nine-month cumulative consolidated period under review was ¥133 million. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period under review.」
The company states that there have been no material changes in its R&D structure across 3 domestic and overseas sites, and discloses R&D activity costs of ¥133 million. - FY2021-Q2RestatedAnnual report
「The group's total research and development expenditure for the cumulative second quarter of the consolidated fiscal year was ¥91 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the consolidated fiscal year.」
The company states that there have been no material changes in its 3-site R&D structure spanning Kasai, Nagasaki and Thailand, and discloses R&D activity costs of ¥91 million. - FY2021-Q1RestatedAnnual report
「Research and development expenditure for the Group as a whole during the three-month cumulative consolidated period under review was ¥46 million. There were no material changes in the status of the Group's research and development activities during the three-month cumulative consolidated period under review.」
The company states that there have been no material changes in its R&D structure across 3 domestic and overseas sites, and discloses cumulative first-quarter R&D activity costs of ¥46 million. - FY2020-Q3RestatedAnnual report
「Research and development expenditure for the Group as a whole during the nine-month cumulative consolidated period under review was ¥134 million. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period under review.」
The company states that there have been no material changes in its 3-site R&D structure spanning Kasai, Nagasaki and Thailand, and discloses R&D activity costs of ¥134 million. - FY2020-Q2RestatedAnnual report
「The group's total research and development expenditure for the cumulative second quarter of the consolidated fiscal year was ¥94 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the consolidated fiscal year.」
The company states that there have been no material changes in its R&D structure across 3 domestic and overseas sites, and discloses R&D activity costs of ¥94 million. - FY2020-Q1RestatedAnnual report
「Research and development expenditure for the Group as a whole during the three-month cumulative consolidated period under review was ¥46 million. There were no material changes in the status of the Group's research and development activities during the three-month cumulative consolidated period under review.」
The company states that there have been no material changes in its 3-site R&D structure spanning Kasai, Nagasaki and Thailand, and discloses R&D activity costs of ¥46 million. - FY2019-Q3RestatedAnnual report
「Research and development expenditure for the Group as a whole during the nine-month cumulative consolidated period under review was ¥122 million. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period under review.」
The company states that there have been no material changes in its 3-site R&D structure spanning Kasai, Nagasaki and Thailand, and discloses R&D activity costs of ¥122 million. - FY2019-Q2RestatedAnnual report
「The group's research and development expenditure for the first half of the consolidated cumulative period was ¥77 million. There were no material changes in the status of the group's research and development activities during the first half of the consolidated cumulative period.」
The company states that there have been no material changes in its 3-site R&D structure spanning Kasai, Nagasaki and Thailand, and discloses R&D activity costs of ¥77 million. - FY2019-Q1RestatedAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated cumulative period was ¥36 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The company states that there have been no material changes in its 3-site R&D structure spanning Kasai, Nagasaki and Thailand, and discloses cumulative first-quarter R&D activity costs of ¥36 million. - FY2018-Q3RestatedAnnual report
「The Group's total research and development expenses for the nine months ended were ¥123 million. There were no significant changes in the status of the Group's research and development activities during the nine months ended.」
The company states that there have been no material changes in its R&D structure across 3 domestic and overseas sites, and discloses cumulative third-quarter R&D activity costs of ¥123 million. - FY2018-Q2RestatedAnnual report
「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30.」
The company states that there have been no material changes in the status of R&D activities at its domestic and overseas R&D sites or in its coordination structure. - FY2018-Q1RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company states that there have been no material changes in its 3-site R&D structure spanning Kasai, Nagasaki and Thailand. - FY2017RestatedAnnual report
「The current R&D structure is centered on the Technical Center within the Kasai Plant, with the Research Center in Nagasaki and the Thailand Technical Center at the Thai subsidiary coordinating their activities in a 3-site R&D structure.」
The company continues its 3-site R&D structure spanning Kasai, Nagasaki and Thailand. R&D expenses were ¥161 million. - FY2017-Q3RestatedAnnual report
「There were no material changes in the status of the Group’s R&D activities during the nine months ended December 31.」
The company states that there have been no material changes in the status of R&D activities at its domestic and overseas R&D sites or in its coordination structure. - FY2017-Q2RestatedAnnual report
「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30.」
The company states that there have been no material changes in the status of R&D activities at its domestic and overseas R&D sites or in its coordination structure. - FY2017-Q1RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company states that there have been no material changes in the status of R&D activities at its domestic and overseas R&D sites or in its coordination structure. - FY2016First statedAnnual report
「To promote the development of next-generation products following its pulley business, the company will use the Technical Center located within the Kasai Plant as its core, while the Research Center in Nagasaki and the Thailand Technical Center at its Thai subsidiary will each enhance their capabilities and coordination, advancing the development and expanded sales of next-generation products using the company’s proprietary technologies.」
The company specifies a structure for developing and expanding sales of next-generation products by coordinating its 3 sites in Kasai, Nagasaki and Thailand.